A Systematic Review on Cost-effectiveness Analyses of Therapeutic Drug Monitoring for Patients with Inflammatory Bowel Disease: From Immunosuppressive to Anti-TNF Therapy

• Published in: Inflammatory bowel diseases Vol. 27; no. 2; pp. 275 - 282
• Main Authors: Yao, Jiaqi, Jiang, Xinchan, You, Joyce H S
• Format: Journal Article
• Language: English
• Published: US Oxford University Press 01.02.2021
• Subjects: Analysis; Clinical outcomes; Cost analysis; Cost benefit analysis; Drug Monitoring; Economic aspects; Evidence-based medicine; Gastrointestinal Agents - therapeutic use; Gastrointestinal diseases; Health aspects; Humans; Immunosuppressive Agents - therapeutic use; Inflammatory bowel disease; Inflammatory Bowel Diseases - drug therapy; Medical research; Medicine, Experimental; Monoclonal antibodies; Patient monitoring equipment; Systematic review; Therapeutic drug monitoring; Tumor necrosis factor; Tumor Necrosis Factor Inhibitors - therapeutic use; quality-adjusted life years; cost; health economic evaluation; inflammatory bowel disease; therapeutic drug monitoring

Abstract Background There is a growing body of primary evidence on the cost-effectiveness of applying therapeutic drug monitoring (TDM) for inflammatory bowel disease (IBD) management with various drug therapies and strategies. Objectives The aim of this study was to conduct a systematic review on m...